#AI Agent #Rosetta #Metareal RR

Unveiling Metareal RR: The Future of Digital Therapy Applications

On October 7, 2025, Rosetta Co., Ltd., a subsidiary of the Metareal Group, will launch the premium plan of its groundbreaking AI agent, Metareal Reinverse Rx (Metareal RR). This innovative service, priced at 50,000 JPY per month (tax included), allows for up to 200 transactions per month, effectively catering to the needs of digital therapy application (DTx) developers by accurately predicting reimbursement odds and timelines.

The Importance of Metareal RR

Digital therapy applications have increasingly gained clinical validation; however, their reimbursement processes can become prolonged and vary from insurer to insurer. Historically, the complexity of creating application materials and uncertainties about approval often lead CFOs to postpone investment decisions in this area. Traditional approaches relied heavily on specialized teams for exhaustive evaluations, consequently slowing down market entry.

So how does Metareal RR change the game? This AI agency employs advanced machine learning algorithms that efficiently analyze historical screening trends alongside clinical evidence to produce data-driven insights into the reimbursement probability of DTx applications. In doing so, it empowers CFOs and management teams to make quick, confident investment decisions.

Key Features of Metareal RR

1. Quantification of Reimbursement Probabilities

One of Metareal RR's standout features is its ability to numerically quantify the reimbursement probabilities based on prior screening results and clinical evidence, offering tailored predictions for each insurer.

2. NLP Document Mapping

Using Natural Language Processing (NLP), Metareal RR automates the analysis of public screening documents and historical materials, highlighting any gaps between requirements and compliance.

3. ROI Optimization Filtering

The AI automatically extracts insurers with reimbursement probabilities of 70% or higher, facilitating the rapid generation of application packs.

Metareal RR is specifically designed for use by CEOs, VPs in Health Economics and Regulatory Strategy, CFOs, and investment decision-makers within DTx companies.

Strengthening AI Consulting Through Sector Specialization

In addition to the launch of Metareal RR, the Metareal Group is committed to expanding its portfolio of AI solutions with the Metareal AI generative series, designed for various industries beyond finance. By addressing specific operational challenges within diverse sectors, these AI solutions provide businesses with straightforward ways to resolve existing issues.

The unique aspect of our AI consulting service lies in its emphasis on speed. While many companies hesitate to adopt new technology due to concerns about disrupting the status quo, we focus on finding ways to rapidly iterate and adapt solutions to real-world scenarios. We have implemented our solutions across different fields, especially in industries where AI adoption has traditionally been challenging, proving our ability to deliver substantial speed and accuracy in the operational integration of AI.

Distinct Features of Metareal AI Consulting

1. Sector Specialization Over Generalization
Leveraging our extensive experience with over 6,000 companies across 2,000 fields, we offer industry-leading specialized know-how and develop AI systems that are immediately applicable to niche business operations.

2. Metareal Agents: Coordinating Multiple LLMs
Our proprietary